The nucleolus: An emerging target for cancer therapy
For over 100 years, pathologists have utilised an increase in size and number of nucleoli, the subnuclear site of ribosome synthesis, as a marker of aggressive tumours. Despite this, the contribution of the nucleolus and ribosomal RNA synthesis to cancer
|Collections||ANU Research Publications|
|Source:||Trends in Molecular Medicine|
|01_Hein_The_nucleolus:_An_emerging_2013.pdf||9.76 MB||Adobe PDF||Request a copy|
Items in Open Research are protected by copyright, with all rights reserved, unless otherwise indicated.